Leukemia Clinical Trials in San Francisco

Showing 881-893 of 893 trials

Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia

NCT00116467

The purpose of this study is to evaluate clinical and laboratory safety associated with the administration of GVAX leukemia vaccine and to determine the feasibility of generation of GVAX leukemia vaccine in subjects with acute myelogenous leukemia (AML).

Acute Myelogenous Leukemia

Cell Genesys55 participantsStarted Mar 2001

San Francisco, California, United States • Chicago, Illinois, United States • Baltimore, Maryland, United States +1 more locations

COMPLETED< 1 mile

Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care

NCT00161668

This study is designed to assess the safety of Mylotarg therapy in routine practice.

Acute Myeloid Leukemia

Wyeth is now a wholly owned subsidiary of Pfizer500 participantsStarted Oct 2001

Tucson, Arizona, United States • Berkely, California, United States • Burbank, California, United States +56 more locations

Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia

Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care

Leukemia Trials in Other Cities

Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)

Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer

A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.

Nasal Irritation Study: Individual Factors in Nasal Irritant Sensitivity

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease

Safety and Immunogenicity Study of LC16m8, a Modified Smallpox Vaccine, in Healthy, Previously Unvaccinated Volunteers

Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Amonafide in Combination With Cytarabine in Secondary AML

Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer

Other Conditions in San Francisco